Joshua Giguere

Joshua Giguere has worked in the pharmaceutical and biotechnology industry since 2008. Joshua began their career at Rhodes Technologies Inc. as a Principal Scientist and Sr. Research Chemist. In 2020, they joined Alexion Pharmaceuticals, Inc. as a Scientist III, Synthetic Chemical Development. Currently, Joshua is the Director, Drug Substance CMC at Imago BioSciences, Inc., a position they have held since 2022.

Joshua Giguere received their Bachelor of Arts degree in Chemistry from College of the Holy Cross in 2001. Joshua then went on to pursue their Ph.D. in Organic Chemistry from Boston University, which they completed in 2008.